Dr. Amy Hermon-Taylor

Dr. Amy Hermon-Taylor is a doctor (GP) from Clapham in London, UK and is the daughter of Prof. John Hermon-Taylor who is leading the world with the development of a modern virally-vectored DNA vaccine against Mycobacterium avium subspecies paratuberculosis (MAP). Amy does not suffer with IBD herself but grew up with the fight to cure Crohn’s Disease as a topic of daily conversation. In gaining a degree in Natural Sciences (Cambridge 1996), a degree in Medicine (St. George’s Medical School, London 2001) and subsequently reading the literature on MAP in Crohn’s Disease extensively for herself, she has come to have a good understanding of the science underpinning the Vaccine research -as well as the integrity of the man behind it.

Read More About Dr. Hermon-Taylor

Patrick McLean

Patrick McLean holds a Bachelor of Science degree in Chemistry from the University of Minnesota. After four years in basic and applied research in protein nutrition, he moved into sales and marketing for J. Hungerford Smith Co., International Multifoods Corporation (US and Canada) and Catelli Ltd (Canada). In 1983 Patrick joined Ralston Purina Co. (Canada) and became Vice President, General Manager for the animal health division. He has spent the past 20 years in the pharmaceutical industry with strategic marketing, communications and operational management responsibilities.

Read More About Patrick

Dr. Michael T. Collins

Michael T. Collins, DVM, PhD, Diplomate ACVM is a professor in the Department of Pathobiological Sciences at the University of Wisconsin School of Veterinary Medicine. He obtained his doctor of veterinary medicine degree from the University of Minnesota and his PhD from the University of Georgia. He has earned the prestigious title of Diplomate of the American College of Veterinary Microbiologists. 

Read More About Dr. Collins